Clinical Trials Browser

Phase 2/3 × vosaroxin × Other hematologic neoplasm × Clear all

NCT02416388 2024-08-07

BIG-1

Phase 2/3 Recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT02272478 2020-01-23

AML18

Phase 2/3 Unknown

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute